The diagnosis of tongue cancer involves clinical examinations, imaging, and pathology, including a biopsy for a definitive diagnosis and, in patients with unresectable or metastatic disease, a PD-L1 combined positive score (CPS) to guide systemic treatment selection with immune checkpoint inhibitors. The gene discussed is CD274; the disease is tongue cancer.